Last reviewed · How we verify

NCT03221725

The Development of De-novo Stress Urinary Incontinence After Stage II-III Pelvic Organ Prolapse Surgery

Completed NA Last updated 30 January 2019
What this trial tests

NA trial testing sacrospinous ligament fixation in Pelvic Organ Prolapse in 100 participants. Completed in 1 February 2018.

Timeline
1 February 2017
Primary endpoint
1 August 2017
1 February 2018

Quick facts

Lead sponsorKanuni Sultan Suleyman Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 February 2017
Primary completion1 August 2017
Estimated completion1 February 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Eligibility, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgery for Stage II-III Pelvic organ prolapse

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of sacrospinous ligament fixation during vaginal hysterectomy on postoperative de novo stress incontinence occurrence: a prospective study with 2-year follow-up
    Başer E, Seçkin KD, Kadiroğullari P, Kiyak H. · · 2020 · cited 4× · PMID 32490650 · DOI 10.3906/sag-2005-117

Verify or expand the search:

Other trials of sacrospinous ligament fixation

Trials testing the same drug.

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03221725.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing